|
Jul 29
|
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
|
|
Jul 29
|
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
|
|
Jul 28
|
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
|
|
Jun 28
|
Fulcrum Therapeutics (NASDAQ:FULC) investors are sitting on a loss of 60% if they invested five years ago
|
|
Apr 8
|
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow
|
|
Feb 18
|
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
|
|
Aug 30
|
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
|
|
Aug 30
|
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data
|
|
Aug 29
|
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
|
Aug 28
|
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
|
Aug 28
|
One Fulcrum Therapeutics Insider Raised Their Stake In The Previous Year
|
|
Aug 28
|
Addex Stock Soars on Crucial Update From Indivior Research Deal
|
|
Aug 28
|
Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
|
|
Aug 27
|
Fulcrum Therapeutics to Participate in Upcoming September Conferences
|
|
Aug 27
|
Insmed Stock Surges 168% in the Past Six Months: Here's Why
|
|
Aug 27
|
Rhythm Stock Up as FDA Accepts Obesity Drug sNDA for Younger Kids
|
|
Aug 27
|
The Zacks Analyst Blog Fulcrum Therapeutics, Heritage Insurance, Latham Group, Seanergy Maritime and BrainsWay
|
|
Aug 26
|
5 Best Small-Cap Stocks to Benefit From Interest Rate Cuts
|
|
Aug 26
|
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|
|
Aug 26
|
Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why
|